‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial

AIM: To evaluate the efficacy and safety of ticagrelor monotherapy beyond 1 month and up to 24 months vs. standard 12-month dual antiplatelet therapy (DAPT) with aspirin and ticagrelor followed by aspirin monotherapy among ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamal, Amr S, Hara, Hironori, Tomaniak, Mariusz, Lunardi, Mattia, Gao, Chao, Ono, Masafumi, Kawashima, Hideyuki, Jüni, Peter, Vranckx, Pascal, Windecker, Stephan, Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Serruys, Patrick W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Scientific Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483765/
https://www.ncbi.nlm.nih.gov/pubmed/34212187
http://dx.doi.org/10.1093/ehjacc/zuab033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483765/
https://www.ncbi.nlm.nih.gov/pubmed/34212187
http://dx.doi.org/10.1093/ehjacc/zuab033

Ejemplares similares